Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study.


Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 21 03 2022
revised: 01 07 2022
accepted: 04 07 2022
pubmed: 16 7 2022
medline: 6 10 2022
entrez: 15 7 2022
Statut: ppublish

Résumé

Among hospital-acquired infections, surgical site infections (SSIs) are frequent. SSI in the early post-transplant course poses a relevant threat to transplant recipients. To determine incidence, risk factors for SSI and its association with post-transplant outcomes and pancreas transplant (P-Tx) recipients. Adult simultaneous kidney-pancreas transplantation (SPK-T) and P-Tx recipients with a follow-up of at least 90 days were identified in the Swiss Transplant Cohort Study (STCS) dataset. Except for the categorization of SSIs according to Centers for Disease Control and Prevention (CDC) criteria, all other data were prospectively collected. Risk factors for SSI were investigated with logistic regression. A Weibull accelerated failure-time model was applied to address the impact of SSI on length of stay, correcting for transplant-related complications and delayed graft function. Of 130 transplant recipients, 108 SPK-Tx and 22 P-Tx, 18 (14%) individuals developed SSI within the first 90 days after transplantation. Deep incisional (seven, 38.9%) and organ/space infections (eight, 44.4%) predominated. In the majority of SSIs (11, 61.1%; two SSIs with simultaneous identification of fungal pathogens) bacteria were detected with Enterococcus spp. being most frequent. The median duration of hospitalization after transplantation was significantly longer in recipients with SSI (median: 26 days; interquartile range (IQR): 19-44) than in patients without SSI (median: 17 days; IQR: 12-25; P = 0.002). In multivariate analysis, SSI was significantly associated with increased length of stay and prolonged the duration of hospitalization by 36% (95% confidence interval: 4-79). SSI after SPK-Tx and P-Tx occurred at a frequency of 14%. Among pathogens, Enterococcus spp. predominated. SSI was independently associated with a longer hospitalization after transplantation.

Sections du résumé

BACKGROUND BACKGROUND
Among hospital-acquired infections, surgical site infections (SSIs) are frequent. SSI in the early post-transplant course poses a relevant threat to transplant recipients.
AIM OBJECTIVE
To determine incidence, risk factors for SSI and its association with post-transplant outcomes and pancreas transplant (P-Tx) recipients.
METHODS METHODS
Adult simultaneous kidney-pancreas transplantation (SPK-T) and P-Tx recipients with a follow-up of at least 90 days were identified in the Swiss Transplant Cohort Study (STCS) dataset. Except for the categorization of SSIs according to Centers for Disease Control and Prevention (CDC) criteria, all other data were prospectively collected. Risk factors for SSI were investigated with logistic regression. A Weibull accelerated failure-time model was applied to address the impact of SSI on length of stay, correcting for transplant-related complications and delayed graft function.
FINDINGS RESULTS
Of 130 transplant recipients, 108 SPK-Tx and 22 P-Tx, 18 (14%) individuals developed SSI within the first 90 days after transplantation. Deep incisional (seven, 38.9%) and organ/space infections (eight, 44.4%) predominated. In the majority of SSIs (11, 61.1%; two SSIs with simultaneous identification of fungal pathogens) bacteria were detected with Enterococcus spp. being most frequent. The median duration of hospitalization after transplantation was significantly longer in recipients with SSI (median: 26 days; interquartile range (IQR): 19-44) than in patients without SSI (median: 17 days; IQR: 12-25; P = 0.002). In multivariate analysis, SSI was significantly associated with increased length of stay and prolonged the duration of hospitalization by 36% (95% confidence interval: 4-79).
CONCLUSION CONCLUSIONS
SSI after SPK-Tx and P-Tx occurred at a frequency of 14%. Among pathogens, Enterococcus spp. predominated. SSI was independently associated with a longer hospitalization after transplantation.

Identifiants

pubmed: 35840001
pii: S0195-6701(22)00224-9
doi: 10.1016/j.jhin.2022.07.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

47-53

Investigateurs

P Amico (P)
J-D Aubert (JD)
V Banz (V)
S Beckmann (S)
G Beldi (G)
C Berger (C)
E Berishvili (E)
A Berzigotti (A)
I Binet (I)
P-Y Bochud (PY)
S Branca (S)
H Bucher (H)
E Catana (E)
A Cairoli (A)
Y Chalandon (Y)
S De Geest (S)
O De Rougemont (O)
S De Seigneux (S)
M Dickenmann (M)
J L Dreifuss (JL)
M Duchosal (M)
T Fehr (T)
S Ferrari-Lacraz (S)
C Garzoni (C)
D Golshayan (D)
N Goossens (N)
F H J Halter (FHJ)
D Heim (D)
C Hess (C)
S Hillinger (S)
H H Hirsch (HH)
P Hirt (P)
G Hofbauer (G)
U Huynh-Do (U)
F Immer (F)
M Koller (M)
M Laager (M)
B Laesser (B)
F Lamoth (F)
R Lehmann (R)
A Leichtle (A)
O Manuel (O)
H P Marti (HP)
M Martinelli (M)
V McLin (V)
K Mellac (K)
A Merçay (A)
K Mettler (K)
A Müller (A)
N J Mueller (NJ)
U Müller-Arndt (U)
B Müllhaupt (B)
M Nägeli (M)
G Oldani (G)
M Pascual (M)
J Passweg (J)
R Pazeller (R)
K Posfay-Barbe (K)
J Rick (J)
A Rosselet (A)
S Rossi (S)
S Rothlin (S)
F Ruschitzka (F)
T Schachtner (T)
U Schanz (U)
S Schaub (S)
A Scherrer (A)
A Schnyder (A)
M Schuurmans (M)
S Schwab (S)
T Sengstag (T)
F Simonetta (F)
S Stampf (S)
J Steiger (J)
G Stirnimann (G)
U Stürzinger (U)
C Van Delden (C)
J-P Venetz (JP)
J Villard (J)
J Vionnet (J)
M Wick (M)
M Wilhelm (M)
P Yerly (P)

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

P W Schreiber (PW)

Division of Infectious Diseases and Hospital Epidemiology and University Zurich, University Hospital Zurich, Zurich, Switzerland. Electronic address: peterwerner.schreiber@usz.ch.

M Laager (M)

Division of Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland.

K Boggian (K)

Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.

D Neofytos (D)

Transplant Infectious Diseases Unit, Service of Infectious Diseases, Department of Medicine, University Hospitals Geneva, University of Geneva, Geneva, Switzerland.

C van Delden (C)

Transplant Infectious Diseases Unit, Service of Infectious Diseases, Department of Medicine, University Hospitals Geneva, University of Geneva, Geneva, Switzerland.

A Egli (A)

Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland; Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.

M Dickenmann (M)

Division of Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland.

C Hirzel (C)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Bern, Bern, Switzerland.

O Manuel (O)

Infectious Diseases Service, University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland; Transplantation Center, University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.

M Koller (M)

Division of Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland.

S Rossi (S)

Division of Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland.

B Schmied (B)

Department of General, Visceral, Endocrine and Transplantation Surgery, Cantonal Hospital St Gallen, St Gallen, Switzerland.

L Gürke (L)

Department of Vascular and Transplant Surgery, Basel University Hospital, Basel, Switzerland.

M Matter (M)

Visceral Surgery Department, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.

T Berney (T)

Department of Surgery, Division of Abdominal and Transplantation Surgery, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.

O de Rougemont (O)

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.

S P Kuster (SP)

Division of Infectious Diseases and Hospital Epidemiology and University Zurich, University Hospital Zurich, Zurich, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.

S Stampf (S)

Division of Transplantation Immunology and Nephrology, Basel University Hospital, Basel, Switzerland.

N J Mueller (NJ)

Division of Infectious Diseases and Hospital Epidemiology and University Zurich, University Hospital Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH